Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

In January, Aldevron unveiled its Alchemy cell-free DNA technology. Instead of using cells to produce DNA, Alchemy relies on enzymes to produce linear DNA that serves as a template for the ...

Lo’s discovery marked a new avenue of inquiry, and over the next 14 years, others confirmed his findings, methods were developed for the analysis of cell-free DNA (cfDNA) to identify fetal ...

We don't have these kinds of studies for the new blood testing, which is called cell-free DNA testing. For the new cell-free DNA testing, a small amount of a person's blood is tested for a large ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant or postpartum women who initially received unusual or nonreportable ...

This so-called cell free DNA can be used to identify cancer at very early stages. In a breakthrough, scientists have now developed a method for detecting small amounts of cell-free RNA. When a cell is ...

"The combination of artificial intelligence, cell-free DNA fragmentomes and a pair of protein biomarkers in a simple blood test improved detection of ovarian cancer even in patients with early ...

In an eight-year study of more than 600 community-dwelling older adults, Johns Hopkins Medicine researchers say they have further linked levels of cell-free DNA (DNA fragments resulting from cell ...

Donor-derived cell-free DNA can aid detection, diagnosis, and monitoring of antibody-mediated rejection after kidney transplantation. Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive ...